Normal view MARC view ISBD view

A denominational worker views the deaf. 3. [electronic resource]

By:

Pokorny, D H

Producer: 19681206Description: 906-9 p. digitalISSN:

0002-726X

Subject(s):

In: American annals of the deaf vol. 113

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

11201 Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial.
by Dixon, Padraig
11202 Diseases due to unhealthy environments: an updated estimate of the global burden of disease attributable to environmental determinants of health.
by Prüss-Ustün, A
11203 Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.
by Sepanlou, Sadaf G
11204 Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy.
by Ansaripour, Amir
11205 Cost Utility of Competing Strategies to Prevent Endoscopic Transmission of Carbapenem-Resistant Enterobacteriaceae.
by Almario, Christopher V
11206 Societal costs of multiple sclerosis in Ireland.
by Carney, Peter
11207 Development of a Pharmacoeconomic Model to Demonstrate the Effect of Clinical Pharmacist Involvement in Diabetes Management.
by Ourth, Heather
11208 The cost-utility of point-of-care troponin testing to diagnose acute coronary syndrome in primary care.
by Kip, Michelle M A
11209 Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes.
by Kim, David D
11210 Cost-Effectiveness of Dolutegravir as a First-Line Treatment Option in the HIV-1-Infected Treatment-Naive Patients in Russia.
by Tremblay, Gabriel
11211 Economic Value of Anti-Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United States.
by Mulligan, Karen
11212 Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy.
by Guzauskas, Gregory F
11213 Global burden of psoriasis - comparison of regional and global epidemiology, 1990 to 2017.
by AlQassimi, Sarah
11214 Secular Trends of Global Burden of Violence, 1990-2015: In Spite of Successes, Women and Children Are Highly Affected in Low- and the Middle-Income Countries.
by Salehi, Alireza
11215 The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication.
by Bosch, J L
11216 Cost-analysis of neonatal intensive and special care.
by Tudehope, D I
11217 Modelling the cost-effectiveness of sentinel lymph node mapping and adjuvant interferon treatment for stage II melanoma.
by Wilson, L S
11218 The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristic.
by Dolan, Paul
11219 The benefits of switching smoking cessation drugs to over-the-counter status.
by Keeler, Theodore E
11220 Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
by Wong, J B